home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

Discovery Chemistry & Drug Design Congress 2013

 
  February 04, 2013  
     
 
Oxford Global Conferences, Geneva, Switzerland
10th&11th June 2013


Agenda

Day 1 – Discovery Chemistry: Latest Case Studies
•              Hit to lead optimisation
•              Structure-activity relationships
•              Optimising allosteric kinase inhibitors
•              Fragment based drug discovery
•              Combinatorial and high-throughput chemistry

Day 2 – Drug Design: Novel Approaches
•              Structure based drug design
•              Anti-target modelling
•              Protein-ligand interactions
•              Antibodies as discovery tools
•              Innovation in IPS cell research
•              Advances in polypharmacology
•              In silico profiling

 
 
Organized by: Oxford Global Conferences
Invited Speakers:
  • Confirmed speakers:

  • Karl-Heinz Baringhaus
    Head of Structure, Design & Informatics, Sanofi Aventis
  • Markus Boehringer
    Head of External Innovation & Alliances Metabolic Diseases, Roche
  • Emilio Diez,
    VP Molecular Discovery Research, GSK
  • José Duca
    Head, Computer-Aided Drug Discovery, Novartis
  • Ivan Efremov
    Senior Principal Scientist, Pfizer
  • David Elder
    Director Scinovo, GSK R&D
  • Matthias Frech,
    Head of Molecular Interactions & Biophysics, Merck
  • Robert Hayes
    Vice President and Venture Leader, Centyrex Venture, Janssen R&D
  • Robert Hayes,
    Vice President, Janssen
  • Patrick Jimonet
    Discovery Sourcing And Leader Global Chemical Library Team, Sanofi
  • Alastair Lawson,
    Senior Director of Structural Biology, UCB
  • Andreas Marzinzik
    Director, Exploratory Medicinal Chemistry, Novartis
  • John Mathias
    Senior Director Head of Medicinal Chemistry, Inflammation & Remodelling, Pfizer
  • Richard Morphy
    , Senior Research Advisor, Eli Lilly
  • Paul Nicklin
    Director, Low Molecular Weight Drug Discovery, Respiratory Diseases Area, Novartis
  • Jens Pohlmann
    Head of Chemistry, Basilea
  • Atli Thorarensen,
    Associate Research Fellow, Pfizer
  • Sjoerd Wadman
    VP R&D, Lanthio Pharma
 
Deadline for Abstracts: NA
 
Registration: For more information and to register: http://www.discoverychemistry-congress1.com/download-agenda/
E-mail: d.meredith@oxfordglobal.co.uk
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.